<DOC>
	<DOCNO>NCT02282670</DOCNO>
	<brief_summary>This multicenter , active-controlled , randomize , double-blinded , paralleled group clinical study evaluate efficacy safety DA-5204 demonstrate non-inferiority DA-5204 compare StillenÂ® tab . patient acute chronic gastritis .</brief_summary>
	<brief_title>A Study Evaluate Efficacy Safety DA-5204</brief_title>
	<detailed_description />
	<mesh_term>Gastritis</mesh_term>
	<mesh_term>Gastritis , Atrophic</mesh_term>
	<criteria>Age 20 year old , 75 year old , men woman Patients diagnose acute chronic gastritis gastroscopy Patients one erosion find gastroscopy Signed inform consent form Patients impossible receive gastroscopy Patients peptic ulcer gastroesophageal reflux disease Patients administer prokinetics , H2 receptor antagonist , proton pump inhibitor , anticholinergic drug nonsteroid antiinflammatory drug prior study 2 week Patients surgery related gastroesophageal Patients ZollingerEllison syndrome Patients kind malignant tumor Patients administer antithrombotic drug Patients significant cardiovascular , pulmonary , heptic , renal , hemopoietic endocrine system primary disease Patients neuropsychiatric disorder , alcoholism , drug abuse Patients take investigational drug participate clinical study 4 week . Women either pregnant breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>